美股詳情

本頁面由Tiger Fintech (Singapore) Pte. Ltd.提供服務

百德醫療

5.59

+0.34006.48%

盤後：5.590.00000.00%16:05 EDT

成交量：3,799.00

成交額：2.09萬

市值：2.00億

市盈率：13.10

高：5.59

開：5.53

低：5.40

收：5.25

資料載入中...

總覽公司新聞公告

拜爾德醫療4月10日成交額為12.56萬美元

拜爾德醫療4月9日成交額為44.54萬美元

拜爾德醫療4月7日成交額為8.17萬美元

拜爾德醫療4月4日成交額為18.31萬美元

拜爾德醫療4月3日成交額為42.04萬美元

Baird Medical Showcases Advanced MWA Technology with UCSF Expert in Guangzhou and Shenzhen

拜爾德醫療3月31日成交額為21.70萬美元

拜爾德醫療3月27日成交額為40.75萬美元

Baird Medical Secures Indonesian Regulatory Approval for Microwave Ablation Technology

Baird Medical Advances MWA Training with Expert-Led Course at Columbia Thyroid Center

Baird Medical Showcases Groundbreaking MWA Innovations at NASIT 2025

Baird Medical Shines at 2025 Microcap Conference: Driving Growth Through Technological Innovation and Strategic Collaborations

Baird Medical Engages with Healthcare Leaders Amid 2025 J.P. Morgan Healthcare Conference

拜爾德醫療暴漲24%，為國內微波消融醫療器械第一大供應商

智通财经网

美股異動 | 拜爾德醫療(BDMD.US)漲逾16% 為國內微波消融醫療器械第一大供應商

蘇州一械企，節前猛漲624%

医疗器械经销商...

美股異動 | 股價暴漲暴跌拜爾德醫療(BDMD.US)盤前大跌逾42%

單月超6億美元，醫藥企業IPO規模重返疫情前水平

美股新股解讀|盈利難題待解，百德醫療(BDMD.US)靠什麼打動投資者？

{"basename":"/hant","ssrTDKData":{"titleTemplate":"%s - 老虎證券","title":"老虎证券全球投资理财平台| 一站式投资美股新股港股A股","description":"老虎证券助您一站式投资美股，新股，港股，A股等全球金融理财产品。新加坡华人最信赖的在线投资平台，现在加入即享低费用，24/5 无时差炒美股投资理财！","keywords":"老虎證券,老虎證券開戶,老虎券商,老虎證券官網,老虎證券app,tigertrade老虎證券,股票,炒股,新加坡股票交易平臺,投資,投資理財","social":{"ogDescription":"老虎证券助您一站式投资美股，新股，港股，A股等全球金融理财产品。新加坡华人最信赖的在线投资平台，现在加入即享低费用，24/5 无时差炒美股投资理财！","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www.itiger.com/hant/stock/BDMD/news"},"companyName":"老虎證券"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"BDMD","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"BDMD\",,,,,undefined,":{"symbol":"BDMD","market":"US","secType":"STK","nameCN":"百德醫療","latestPrice":5.59,"timestamp":1744920000000,"preClose":5.25,"halted":0,"volume":3799,"hourTrading":{"tag":"盘后","latestPrice":5.59,"preClose":5.59,"latestTime":"16:05 EDT","volume":337,"amount":1953.2,"timestamp":1744920323115},"delay":0,"floatShares":10638480,"shares":35778625,"eps":0.42656,"marketStatus":"休市中","change":0.34,"latestTime":"04-17 16:00:00 EDT","open":5.53,"high":5.59,"low":5.4,"amount":20861.8326,"amplitude":0.03619,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":0,"ttmEps":0.42656,"tradingStatus":0,"nextMarketStatus":{"tag":"盤前交易","tradingStatus":1,"beginTime":1745222400000},"marketStatusCode":7,"adr":0,"exchange":"NASDAQ","adjPreClose":5.25,"preHourTrading":{"tag":"盘前","latestPrice":5.74,"preClose":5.25,"latestTime":"08:59 EDT","volume":15,"amount":86.10000000000001,"timestamp":1744894784983},"postHourTrading":{"tag":"盘后","latestPrice":5.59,"preClose":5.59,"latestTime":"16:05 EDT","volume":337,"amount":1953.2,"timestamp":1744920323115},"volumeRatio":0.18294150957891206},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"BDMD\",,,,,undefined,":{"symbol":"BDMD","floatShares":10638480,"roa":"41.84%","roe":"199.74%","lyrEps":0.358563,"volumeRatio":0.18294150957891206,"shares":35778625,"dividePrice":0,"high":5.59,"amplitude":0.03619,"preClose":5.25,"low":5.4,"week52Low":1.05,"pbRate":"5.10","psRate":"6.05","week52High":13.52,"institutionHeld":0,"latestPrice":5.59,"eps":0.42656,"divideRate":0,"volume":3799,"delay":0,"ttmEps":0.42656,"open":5.53,"prevYearClose":7.6,"prevWeekClose":5.04,"prevMonthClose":5.21,"prevQuarterClose":5.21,"fiveDayClose":4.91,"twentyDayClose":5.62,"sixtyDayClose":7.02},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"BDMD\",pageSize:20,pageCount:1,lang_content:\"cn\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2526210578","title":"拜爾德醫療4月10日成交額為12.56萬美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2526210578","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2526210578?lang=zh_tw&edition=fundamental","pubTime":"2025-04-11 09:17","pubTimestamp":1744334230,"startTime":"0","endTime":"0","summary":"美东时间2025年4月10日，拜尔德医疗成交额为12.56万美元，成交额较昨日减少71.80%，当日成交量为2.46万股。拜尔德医疗于2025年4月10日跌8.05%，报4.91美元，该股过去5个交易日跌14.46%，年初至今跌35.39%，过去60日跌36.48%。其专有的医疗设备用于治疗良性和恶性肿瘤，包括甲状腺结节、肝癌、肺癌和乳腺肿块。微波消融治疗已应用于良性和恶性肿瘤，公司认为与传统治疗方法相比，该产品更安全、微创、更容易操作，患者恢复期更快，并发症发生率更低。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250411091724a4559274&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250411091724a4559274&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BDMD","BK4082"],"gpt_icon":0},{"id":"2526732402","title":"拜爾德醫療4月9日成交額為44.54萬美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2526732402","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2526732402?lang=zh_tw&edition=fundamental","pubTime":"2025-04-10 09:17","pubTimestamp":1744247827,"startTime":"0","endTime":"0","summary":"美东时间2025年4月9日，拜尔德医疗成交额为44.54万美元，成交额较昨日增加127.12%，当日成交量为8.41万股。拜尔德医疗于2025年4月9日跌3.26%，报5.34美元，该股过去5个交易日跌2.91%，年初至今跌29.74%，过去60日跌51.94%。其专有的医疗设备用于治疗良性和恶性肿瘤，包括甲状腺结节、肝癌、肺癌和乳腺肿块。微波消融治疗已应用于良性和恶性肿瘤，公司认为与传统治疗方法相比，该产品更安全、微创、更容易操作，患者恢复期更快，并发症发生率更低。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250410091725a45451e3&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250410091725a45451e3&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BDMD","BK4082"],"gpt_icon":0},{"id":"2525000257","title":"拜爾德醫療4月7日成交額為8.17萬美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2525000257","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2525000257?lang=zh_tw&edition=fundamental","pubTime":"2025-04-08 09:17","pubTimestamp":1744075038,"startTime":"0","endTime":"0","summary":"美东时间2025年4月7日，拜尔德医疗成交额为8.17万美元，成交额较昨日减少55.36%，当日成交量为1.47万股。拜尔德医疗于2025年4月7日跌5.55%，报5.62美元，该股过去5个交易日涨7.87%，年初至今跌26.05%，过去60日跌26.54%。其专有的医疗设备用于治疗良性和恶性肿瘤，包括甲状腺结节、肝癌、肺癌和乳腺肿块。微波消融治疗已应用于良性和恶性肿瘤，公司认为与传统治疗方法相比，该产品更安全、微创、更容易操作，患者恢复期更快，并发症发生率更低。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250408091724a6b357e8&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250408091724a6b357e8&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BDMD","BK4082"],"gpt_icon":0},{"id":"2525750398","title":"拜爾德醫療4月4日成交額為18.31萬美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2525750398","media":"市场透视","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2525750398?lang=zh_tw&edition=fundamental","pubTime":"2025-04-05 09:17","pubTimestamp":1743815844,"startTime":"0","endTime":"0","summary":"美东时间2025年4月4日，拜尔德医疗成交额为18.31万美元，成交额较昨日减少56.45%，当日成交量为3.25万股。拜尔德医疗于2025年4月4日涨3.66%，报5.95美元，该股过去5个交易日涨7.99%，年初至今跌21.71%，过去60日跌20.88%。其专有的医疗设备用于治疗良性和恶性肿瘤，包括甲状腺结节、肝癌、肺癌和乳腺肿块。微波消融治疗已应用于良性和恶性肿瘤，公司认为与传统治疗方法相比，该产品更安全、微创、更容易操作，患者恢复期更快，并发症发生率更低。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250405091727a44e60f1&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250405091727a44e60f1&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BDMD","BK4082"],"gpt_icon":0},{"id":"2524442241","title":"拜爾德醫療4月3日成交額為42.04萬美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2524442241","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2524442241?lang=zh_tw&edition=fundamental","pubTime":"2025-04-04 09:17","pubTimestamp":1743729440,"startTime":"0","endTime":"0","summary":"美东时间2025年4月3日，拜尔德医疗成交额为42.04万美元，成交额较昨日增加265.14%，当日成交量为7.02万股。拜尔德医疗于2025年4月3日涨4.36%，报5.74美元，该股过去5个交易日跌3.04%，年初至今跌24.47%，过去60日跌14.33%。其专有的医疗设备用于治疗良性和恶性肿瘤，包括甲状腺结节、肝癌、肺癌和乳腺肿块。微波消融治疗已应用于良性和恶性肿瘤，公司认为与传统治疗方法相比，该产品更安全、微创、更容易操作，患者恢复期更快，并发症发生率更低。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250404091727a6af2877&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250404091727a6af2877&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4082","BDMD"],"gpt_icon":0},{"id":"1186052222","title":"Baird Medical Showcases Advanced MWA Technology with UCSF Expert in Guangzhou and Shenzhen","url":"https://stock-news.laohu8.com/highlight/detail?id=1186052222","media":"prnewswire","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1186052222?lang=zh_tw&edition=fundamental","pubTime":"2025-04-03 17:56","pubTimestamp":1743674164,"startTime":"0","endTime":"0","summary":"NEW YORK, April 2, 2025 /PRNewswire/ -- Baird Medical Investment Holdings Ltd.  (\"Baird Medical\" or the \"Company\") proudly hosted Dr. Quan-Yang Duh, a world-renowned endocrine surgeon and Chief of End","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.prnewswire.com/news-releases/baird-medical-showcases-advanced-mwa-technology-with-ucsf-expert-in-guangzhou-and-shenzhen-302418226.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"prnewswire","symbols":["BDMD"],"gpt_icon":0},{"id":"2524185601","title":"拜爾德醫療3月31日成交額為21.70萬美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2524185601","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2524185601?lang=zh_tw&edition=fundamental","pubTime":"2025-04-01 09:17","pubTimestamp":1743470233,"startTime":"0","endTime":"0","summary":"美东时间2025年3月31日，拜尔德医疗成交额为21.70万美元，成交额较昨日增加53.99%，当日成交量为4.08万股。拜尔德医疗于2025年3月31日跌5.44%，报5.21美元，该股过去5个交易日跌8.11%，年初至今跌31.45%，过去60日跌31.45%。其专有的医疗设备用于治疗良性和恶性肿瘤，包括甲状腺结节、肝癌、肺癌和乳腺肿块。微波消融治疗已应用于良性和恶性肿瘤，公司认为与传统治疗方法相比，该产品更安全、微创、更容易操作，患者恢复期更快，并发症发生率更低。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250401091730a6ab3595&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250401091730a6ab3595&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BDMD","BK4082"],"gpt_icon":0},{"id":"2522569128","title":"拜爾德醫療3月27日成交額為40.75萬美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2522569128","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2522569128?lang=zh_tw&edition=fundamental","pubTime":"2025-03-28 09:17","pubTimestamp":1743124633,"startTime":"0","endTime":"0","summary":"美东时间2025年3月27日，拜尔德医疗成交额为40.75万美元，成交额较昨日减少29.75%，当日成交量为6.45万股。拜尔德医疗于2025年3月27日跌1.4%，报5.92美元，该股过去5个交易日涨5.34%，年初至今跌22.11%，过去60日涨244.19%。其专有的医疗设备用于治疗良性和恶性肿瘤，包括甲状腺结节、肝癌、肺癌和乳腺肿块。微波消融治疗已应用于良性和恶性肿瘤，公司认为与传统治疗方法相比，该产品更安全、微创、更容易操作，患者恢复期更快，并发症发生率更低。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250328091723a6a6c01b&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250328091723a6a6c01b&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4082","BDMD"],"gpt_icon":0},{"id":"1130988240","title":"Baird Medical Secures Indonesian Regulatory Approval for Microwave Ablation Technology","url":"https://stock-news.laohu8.com/highlight/detail?id=1130988240","media":"prnewswire","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1130988240?lang=zh_tw&edition=fundamental","pubTime":"2025-03-11 11:18","pubTimestamp":1741663125,"startTime":"0","endTime":"0","summary":"NEW YORK, March 10, 2025 /PRNewswire/ -- Baird Medical Investment Holdings Ltd. (NASDAQ: BDMD) (\"Baird Medical\" or the \"Company\"), a forward-thinking medical device company specializing in AI-powered ","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.prnewswire.com/news-releases/baird-medical-secures-indonesian-regulatory-approval-for-microwave-ablation-technology-302396592.html?tc=eml_cleartime","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"prnewswire","symbols":["BDMD"],"gpt_icon":0},{"id":"1160450135","title":"Baird Medical Advances MWA Training with Expert-Led Course at Columbia Thyroid Center","url":"https://stock-news.laohu8.com/highlight/detail?id=1160450135","media":"prnewswire","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1160450135?lang=zh_tw&edition=fundamental","pubTime":"2025-02-11 16:42","pubTimestamp":1739263338,"startTime":"0","endTime":"0","summary":"Baird Medical Investment Holdings Ltd. (NASDAQ: BDMD) (\"Baird Medical\" or the \"Company\"), a leader in microwave ablation (MWA) technology, remains committed to advancing physician education and recent","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.prnewswire.com/news-releases/baird-medical-advances-mwa-training-with-expert-led-course-at-columbia-thyroid-center-302371852.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"prnewswire","symbols":["BDMD"],"gpt_icon":0},{"id":"1194485441","title":"Baird Medical Showcases Groundbreaking MWA Innovations at NASIT 2025","url":"https://stock-news.laohu8.com/highlight/detail?id=1194485441","media":"prnewswire","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1194485441?lang=zh_tw&edition=fundamental","pubTime":"2025-02-03 21:40","pubTimestamp":1738590024,"startTime":"0","endTime":"0","summary":"Baird Medical is a leading provider of minimally invasive microwave ablation (MWA) technology。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.prnewswire.com/news-releases/baird-medical-showcases-groundbreaking-mwa-innovations-at-nasit-2025-302366242.html?tc=eml_cleartime","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"prnewswire","symbols":["BDMD"],"gpt_icon":0},{"id":"1184927493","title":"Baird Medical Shines at 2025 Microcap Conference: Driving Growth Through Technological Innovation and Strategic Collaborations","url":"https://stock-news.laohu8.com/highlight/detail?id=1184927493","media":"prnewswire","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1184927493?lang=zh_tw&edition=fundamental","pubTime":"2025-01-30 21:38","pubTimestamp":1738244293,"startTime":"0","endTime":"0","summary":"NEW YORK, Jan. 30, 2025 /PRNewswire/ -- Baird Medical Investment Holdings Ltd. (NASDAQ: BDMD) (\"Baird Medical\" or the \"Company\"), a leader in microwave ablation (MWA) technology, today announced its s","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.prnewswire.com/news-releases/baird-medical-shines-at-2025-microcap-conference-driving-growth-through-technological-innovation-and-strategic-collaborations-302363962.html?tc=eml_cleartime","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"prnewswire","symbols":["BDMD"],"gpt_icon":0},{"id":"1126482238","title":"Baird Medical Engages with Healthcare Leaders Amid 2025 J.P. Morgan Healthcare Conference","url":"https://stock-news.laohu8.com/highlight/detail?id=1126482238","media":"prnewswire","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1126482238?lang=zh_tw&edition=fundamental","pubTime":"2025-01-20 13:58","pubTimestamp":1737352729,"startTime":"0","endTime":"0","summary":"NEW YORK, Jan. 17, 2025 /PRNewswire/ -- Baird Medical Investment Holdings Ltd. (\"Baird Medical\" or the \"Company\"), a leader in minimally invasive Microwave Ablation (MWA) technology, was present in Sa","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.prnewswire.com/news-releases/baird-medical-engages-with-healthcare-leaders-amid-2025-jp-morgan-healthcare-conference-302353999.html?tc=eml_cleartime","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"prnewswire","symbols":["BDMD"],"gpt_icon":0},{"id":"1195951781","title":"拜爾德醫療暴漲24%，為國內微波消融醫療器械第一大供應商","url":"https://stock-news.laohu8.com/highlight/detail?id=1195951781","media":"智通财经网","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1195951781?lang=zh_tw&edition=fundamental","pubTime":"2025-01-03 23:48","pubTimestamp":1735919318,"startTime":"0","endTime":"0","summary":"国内微波消融医疗器械第一大供应商。","market":"us","thumbnail":"https://static.tigerbbs.com/f7f16c2e65374ebb434bfff94a418cbc","type":0,"news_type":0,"thumbnails":["https://static.tigerbbs.com/f7f16c2e65374ebb434bfff94a418cbc"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.zhitongcaijing.com/content/detail/1233404.html","is_publish_highlight":true,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["BDMD"],"gpt_icon":0},{"id":"2500128311","title":"美股異動 | 拜爾德醫療(BDMD.US)漲逾16% 為國內微波消融醫療器械第一大供應商","url":"https://stock-news.laohu8.com/highlight/detail?id=2500128311","media":"智通财经","labels":["movement"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2500128311?lang=zh_tw&edition=fundamental","pubTime":"2025-01-03 22:51","pubTimestamp":1735915880,"startTime":"0","endTime":"0","summary":"智通财经APP获悉，周五，拜尔德医疗(BDMD.US)涨逾16%，报5.95美元。资料显示，拜尔德医疗是国内领先的微波消融医疗企业。在治疗甲状腺结节及乳腺结节领域，拜尔德医疗是国内微波消融医疗器械第一大供应商。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1233404.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"movement","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["BK1574","BDMD","BK4082","BK1100","BK1583","159883","BK1222","09996","159891","09997"],"gpt_icon":0},{"id":"2500994201","title":"蘇州一械企，節前猛漲624%","url":"https://stock-news.laohu8.com/highlight/detail?id=2500994201","media":"医疗器械经销商...","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2500994201?lang=zh_tw&edition=fundamental","pubTime":"2025-01-03 18:53","pubTimestamp":1735901580,"startTime":"0","endTime":"0","summary":"截至该年的最后一个交易日，即12月31日，股价飙升了623.81%，从之前的低点1.05美元跃升至7.60美元。随着此次并购，百德医疗得以从传统的分销商转变为集研发与制造于一体的高科技医疗器械公司，正式进军微波消融市场。由于未能满足2021年的业绩承诺，百德医疗面临潜在的赔偿责任。在国内市场占据领先地位的百德医疗成功赴美上市，这一举动吸引了众多海外投资者的目光，并促成了其近日股价飙升超过600%。","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.sina.com.cn/roll/2025-01-03/doc-inectaav1413200.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"sina","symbols":["BDMD"],"gpt_icon":0},{"id":"2500924002","title":"美股異動 | 股價暴漲暴跌 拜爾德醫療(BDMD.US)盤前大跌逾42%","url":"https://stock-news.laohu8.com/highlight/detail?id=2500924002","media":"智通财经","labels":["movement"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2500924002?lang=zh_tw&edition=fundamental","pubTime":"2025-01-02 22:27","pubTimestamp":1735828027,"startTime":"0","endTime":"0","summary":"智通财经APP获悉，继周二股价暴涨近624%之后，周四，拜尔德医疗(BDMD.US)美股盘前大跌逾42%，报4.40美元。资料显示，拜尔德医疗是国内领先的微波消融医疗企业。在治疗甲状腺结节及乳腺结节领域，拜尔德医疗是国内微波消融医疗器械第一大供应商。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1232842.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-2","news_top_title":null,"news_tag":"movement","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["BDMD","159891","BK4082"],"gpt_icon":0},{"id":"2486705257","title":"單月超6億美元，醫藥企業IPO規模重返疫情前水平","url":"https://stock-news.laohu8.com/highlight/detail?id=2486705257","media":"财通社","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2486705257?lang=zh_tw&edition=fundamental","pubTime":"2024-11-25 17:34","pubTimestamp":1732527240,"startTime":"0","endTime":"0","summary":"今年以来，生物医药领域已经有30家公司IPO上市，累计融资规模超40.49亿美元，其中不乏CG Oncology、Kyverna Therapeutics等IPO规模超3亿美元的公司。在多肽类PTH1R激动剂领域，阿斯利康以总价18亿美元收购AmolytPharma，获得了处于临床3期的PTH1R激动剂eneboparatide，目前该疗法已经获得了FDA快速通道认定，另一家药企AscendisPharma的Yorvipath获得FDA批准上市，用于治疗成人慢性甲状旁腺功能减退。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.sina.com.cn/roll/2024-11-25/doc-incxhqmk8147031.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"sina","symbols":["QLD","OMGA","AVTE","BK4020","SYRS","NQmain","GPCR","GLYC","BK4200","BK4139","BK4539","TSLP","QID","MNQmain","BK4007","PSQ","BK4082",".IXIC","SQQQ","SEPN","APGE","UPB","BDMD","BK4561","CAMP","ASO","BK4599","TQQQ"],"gpt_icon":1},{"id":"2481599264","title":"美股新股解讀|盈利難題待解，百德醫療(BDMD.US)靠什麼打動投資者？","url":"https://stock-news.laohu8.com/highlight/detail?id=2481599264","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2481599264?lang=zh_tw&edition=fundamental","pubTime":"2024-11-07 09:55","pubTimestamp":1730944558,"startTime":"0","endTime":"0","summary":"此前，百德医疗的上市之路十分曲折。然而，从市场走势来看，百德医疗自上市以来股价一路下跌，10月以来股价跌去62%，显然并未受到市场投资者看好。招股书显示，百德医疗共有8款产品，其中3款已经获得上市批准，分别是用于治疗肝癌和甲状腺结节的微波消融治疗仪和微波消融针、长型微波消融针以及精细型微波消融针。若想恢复市场投资者的信心，百德医疗未来还将面临诸多挑战。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1207798.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["90072","06678","BK4082","BDMD"],"gpt_icon":0}],"pageSize":20,"totalPage":1,"pageCount":1,"totalSize":19,"code":"91000000","status":"200"}],"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/BDMD\",params:#limit:5,,,undefined,":[{"market":"US","date":"2024-10-02","symbol":"BDMD","reason":null,"defaultRemindTime":1727875800000,"announcedDate":"2023-09-21","type":"delisting","dateTimestamp":1727841600000}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"BDMD\",market:\"US\",,,undefined,":[],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"BDMD\",market:\"US\",delay:false,,,undefined,":{},"@#url:\"https://hq.skytigris.cn/value_analysis/stock/BDMD\",params:#withQuantilePoint:true,period:\"5year\",factor:\"peRate\",delay:false,algorithm:1,,,undefined,":{"brief":{"id":"BDMD","date":"2025-04-17","current":14.972062,"percent":0.572519,"low":1.372647,"twenty":2.817256,"median":11.435803,"eighty":17.247815,"high":31.683735,"avg":11.097013,"sd":7.190106,"marketCap":187837781},"quantilePoints":[{"date":"2024-10-11","current":1.994211,"twenty":2.351466,"median":2.475334,"eighty":2.707089,"marketCap":25019146},{"date":"2024-10-18","current":1.605865,"twenty":1.699278,"median":1.897124,"eighty":2.518391,"marketCap":20146997},{"date":"2024-10-25","current":1.658344,"twenty":1.622658,"median":1.710823,"eighty":2.447691,"marketCap":20805395},{"date":"2024-10-31","current":1.443179,"twenty":1.605865,"median":1.658344,"eighty":2.172839,"marketCap":18105961},{"date":"2024-11-08","current":1.569129,"twenty":1.560733,"median":1.637352,"eighty":1.877707,"marketCap":19686118},{"date":"2024-11-15","current":7.148882,"twenty":1.558109,"median":1.626856,"eighty":2.172839,"marketCap":89689054},{"date":"2024-11-22","current":6.668522,"twenty":1.56598,"median":1.65572,"eighty":4.331189,"marketCap":83662516},{"date":"2024-11-29","current":6.92283,"twenty":1.571228,"median":1.708199,"eighty":6.737016,"marketCap":86853036},{"date":"2024-12-06","current":5.361424,"twenty":1.574377,"median":1.800038,"eighty":6.782226,"marketCap":67263815},{"date":"2024-12-13","current":4.448841,"twenty":1.578575,"median":2.458057,"eighty":6.736338,"marketCap":55814655},{"date":"2024-12-20","current":6.644744,"twenty":1.59327,"median":2.772967,"eighty":6.659011,"marketCap":83364196},{"date":"2024-12-27","current":5.076242,"twenty":1.605865,"median":4.420323,"eighty":6.615592,"marketCap":63685952},{"date":"2025-01-03","current":14.601325,"twenty":1.605865,"median":4.420323,"eighty":6.668522,"marketCap":183186560},{"date":"2025-01-10","current":21.816433,"twenty":1.614262,"median":4.534396,"eighty":6.900225,"marketCap":273706481},{"date":"2025-01-17","current":15.456871,"twenty":1.624757,"median":4.948053,"eighty":7.001948,"marketCap":193920147},{"date":"2025-01-24","current":23.242344,"twenty":1.639451,"median":5.027475,"eighty":10.698831,"marketCap":291595793},{"date":"2025-01-31","current":20.761259,"twenty":1.650997,"median":5.076242,"eighty":18.970315,"marketCap":260468390},{"date":"2025-02-07","current":17.053891,"twenty":1.656245,"median":5.311517,"eighty":19.152832,"marketCap":213956177},{"date":"2025-02-14","current":17.823883,"twenty":1.686683,"median":5.933854,"eighty":18.970315,"marketCap":223616406},{"date":"2025-02-21","current":17.253519,"twenty":1.707674,"median":6.498983,"eighty":18.673726,"marketCap":216460681},{"date":"2025-02-28","current":10.722848,"twenty":1.721319,"median":6.725035,"eighty":18.183213,"marketCap":134527630},{"date":"2025-03-07","current":11.521358,"twenty":1.762253,"median":6.894574,"eighty":17.875216,"marketCap":144545645},{"date":"2025-03-14","current":15.713535,"twenty":1.877707,"median":6.92283,"eighty":17.801069,"marketCap":197140223},{"date":"2025-03-21","current":16.027236,"twenty":2.172839,"median":7.092369,"eighty":17.766847,"marketCap":201075872},{"date":"2025-03-28","current":16.882782,"twenty":2.454602,"median":9.082048,"eighty":17.607145,"marketCap":211809460},{"date":"2025-04-04","current":16.369454,"twenty":2.561448,"median":10.722848,"eighty":17.344777,"marketCap":205369307},{"date":"2025-04-11","current":14.002443,"twenty":2.723559,"median":11.022289,"eighty":17.287741,"marketCap":175673048},{"date":"2025-04-17","current":14.972062,"twenty":2.817256,"median":11.435803,"eighty":17.247815,"marketCap":187837781}],"updateTime":1745101533274}}}